Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Blood|February 24, 2016
Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemiaAldo M Roccaro, Antonio Sacco, Jiantao Shi, et al.
International Journal of Biological Sciences|October 20, 2022
Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2Limin Wang, Julián Candia, Lichun Ma, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 31, 2013
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study groupAntonio Bertolotto, Marco Capobianco, Maria Pia Amato, et al.
Frontiers in Neurology|January 2, 2023
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapiesEli Hatchwell, Edward B Smith, Shapour Jalilzadeh, et al.
Neurology|August 9, 2013
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patientsNicholas Schwab, Tilman Schneider-Hohendorf, Vilmos Posevitz, et al.
Cell|March 13, 2021
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19Can Liu, Andrew J Martins, William W Lau, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2021
Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunityOttavia M Delmonte, Jenna R E Bergerson, Peter D Burbelo, et al.
Frontiers in Immunology|April 1, 2022
Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-CPeter D Burbelo, Riccardo Castagnoli, Chisato Shimizu, et al.
The Journal of Experimental Medicine|February 3, 2017
EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delayStefano Volpi, Yasuhiro Yamazaki, Patrick M Brauer, et al.
JCI Insight|April 1, 2025
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infectionPei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.
Pageof 13